Clinical Assessment of the New Tumor Marker TPS

Frey Bm,Rudolf Morant,H. J. Senn,W.F. Riesen

Clinical Assessment of the New Tumor Marker TPS

1994

Frey Bm
Rudolf Morant
H. J. Senn
W.F. Riesen

Background: TPS (Tissue Polypeptide Specific Antigen) is defined by a monoclonal antibody against an epitope of the soluble Tissue Polypeptide Antigen (TPA). It is considered to be

Keywords:

Tissue Polypeptide Antigen
Tumor marker
Epitope
CA19-9
Pathology
Lung cancer
Tissue Polypeptide Specific Antigen
Gastrointestinal cancer
Monoclonal antibody
Medicine
Molecular biology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations